Ceryx Condusts First-In-Human Study of Cysoni Pacemaker for Heart Failure Patients Ceryx Medical Ltd has initiated the first-in-human study of its Cysoni™ RSA Pacemaker’s potential to provide superior treatment for heart failure patients by boosting cardiac output through Respiratory Sinus Arrhythmia (RSA) inputs. Read more: https://nextdigitalhealth.com/healthcare/cardiac-care/ceryx-condusts-first-in-human-study-of-cysoni-pacemaker-for-heart-failure-patients/ #HealthcareNews #HealthcareInnovation #HealthcareTechnology #Ai #Medicaldevice